• Electrical microstimulation to modulate neural activity has emerged as a critical tool in brain research, neurotherapeutics, and bidirectional neuroprostheses. • Recent successes in sensory, motor, auditory, visual, and cognitive neuroprostheses demonstrate a need for more focal micro-neuromodulation technologies.
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manufacturing for greater abiotic stability [41] [42] [43] as well as mitigation of the FBR [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] are concurrently being investigated.
The requirements from the latest breakthroughs in microstimulation-based neuroprostheses, as well as state-of-the-art advances in neuromodulation technologies, suggest that the field is naturally progressing towards multichannel micro-neuromodulation. These technologies are shifting the stimulation spatial resolution scale from the network level to the cellular (and sub-cellular) level. The perceived quality and adaptability of future prosthetics will be bolstered by advances in neuroscience, the consolidation of functional maps with neuronal resolution, and the ability to selectively modulate those neurons. For the remainder of this review, we will discuss current successes in sensory, motor, and cognitive prostheses. We will then highlight novel technologies that are overcoming drawbacks that may one day enable whole brain micro-neuromodulation. Figure 
1.
Overview of stimulation spatial resolution and its effects on somatosensory and visual neuroprostheses. (A) Low spatial resolution stimulation inducing blunt visual and sensory percepts. (B) High spatial resolution neuromodulation showing discrete activation of neuronal clusters. This increase in stimulation specificity will likely allow for higher quality, more naturalistic neuroprostheses.
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A C C E P T E D ACCEPTED MANUSCRIPT lower stimulation thresholds than AMI and ABI [89] . Lastly, primary auditory cortex microstimulation stands as a prospective target for auditory neuroprostheses. Otto et al. used a discrimination task to assess intracortical microstimulation of the auditory cortex of behaving rats. The results of these experiments indicated that the tonotopic location of the microelectrode correlates with the perceived frequency of the stimulus [90, 91] . Moreover, microstimulation evoked faster responses than natural hearing [91] . Similar tonotopic activation has been reported in human electrical stimulation [92] , and fMRI studies [93] , suggesting potential translatability of these interfaces.
The aforementioned experiments have identified promising auditory neuroprosthetic targets that might, one day, restore normal hearing of deaf patients. The emergence of massively parallel microneuromodulation channels that can stimulate small neuronal populations independently will likely continue to add to the quality of auditory sensation, limiting the perceived frequency spread and enhancing the temporal resolution.
Visual Neuroprostheses
The potential of microstimulation to restore sight for the blind was established after the finding more than 80 years ago that stimulation of the visual cortex elicited localized phosphenes [94] . Since then, several potential visual neuroprosthetic targets along the visual pathway have been identified. Moreover, neural implants have shown substantial restoration of sight in low-vision patients. Retinal implants have shown great clinical and commercial success, enabling substantial improvements in motion detection, word recognition, and acuity tasks in blind patients [95, 96] (See: [97] for an extended review). Despite these successes, due to anatomical constraints, retinal implants may never offer extreme high-resolution artificial vision. However, the visual cortex offers great potential for highresolution visual prostheses [98] . The feasibility of visual cortex implants was recognized by human trials [99] [100] [101] . These experiments led to important insights and considerations for future developments of visual cortex prostheses and neural implants in general, including the importance of spatial resolution and proper neuromodulation parameters. For instance, the charge necessary to reach threshold and evoke phosphenes of intracortical (penetrating) electrodes was orders of magnitude lower compared with cortical surface stimulation [101, 102] . Likewise, high stimulation currents disrupted the color and quality of evoked phosphenes [101] . Furthermore, electrodes separated by at least 0.5 mm were able to elicit independent phosphenes. Currently, multidisciplinary efforts to develop a reliable visual cortex implants have been recently proposed [103] [104] [105] (see [106] for a review). Yet, several scientific and technological challenges must be overcome before the implementation of fully functional visual cortex prostheses. For instance, a detailed understanding of the encoding used within the primary visual and striate cortices can result in enriched receptive field mapping [107] and phosphene prediction models [108] . Combining these topographic models with specific spatiotemporal neuromodulation can potentially elicit real-time, high-quality percepts. Along the same lines, experiments in NHP suggest that microstimulation of visual association areas influences object perception, including direction [109] and faces [110] . Hence, coordinated neuromodulation of visual cortex with visual association areas could potentially alter the perception and connotation of elicited phosphenes. See [111] for an extended review. Moreover, future prosthetic implementations must take into account the role of training and plasticity in chronic functional implants. Additionally, alternative stimulation targets, such as the optic nerve [112, 113] and lateral geniculate nucleus (LGN) [114] , have been studied for neuroprosthetic interfaces. Though still in development, advances in high-resolution brain mapping and microneuromodulation will likely improve the visual resolution of the perceived images, as well as the spatial patterns observed during natural vision, in all of these visual prosthesis targets [101] (Fig. 1 -Bottom) .
Motor Neuroprostheses
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Even though direct neuromodulation of motor cortex for locomotion has been challenging due to the lack of fine motor tuning [115] and its impracticality in spinal cord injury patients [116] , it has been widely used for brain mapping [117, 118] and functional neurorehabilitation [119, 120] . Typically, motor cortex serves as the efferent component of bidirectional brain-machine interfaces. Recordings from primary motor cortex serve to direct neuromodulation of specific targets, including the spinal cord (via intraspinal microstimulation (ISMS) or epidural stimulation) and functional electrical stimulation for the periphery [121] . These approaches have recently allowed paralyzed NHPs to reach and grasp [122, 123] , and effectively restore leg locomotion [34] . Moreover, recent human trials have shown successful limb control in paralyzed patients [124, 125] . Although, aside from ISMS, these stimulation techniques are not strictly classified as microstimulation, high spatiotemporal resolution neuromodulation has the potential to continue to improve the overall sustainability and naturalistic performance of these interfaces. Focal neuromodulation can substantially help overcome some of the challenges facing current motor prostheses. These include the need to drastically reduce muscle fatigue, electrical spillover, and high power consumption [126] . Moreover, micro-neuromodulation in combination with functional mapping would drastically enhance selective control of independent muscular bundles for fine motor control [127] . Finally, the chronic stability of both recording and stimulating interfaces (see Invasive Neuromodulation section) is necessary for closed-loop motor and touch integration in the translation of future, fully-functional clinical motor neuroprostheses [75] .
Cognitive Neuroprostheses
Restoration of cognitive abilities has emerged as an intriguing micro-neuromodulation target. Microstimulation of hippocampal cells demonstrated enhancements in memory performance tasks in rodents [128] and NHPs [129] . These microstimulation experiments were feasible by a nonlinear multiinput multi-output (MIMO) model that allowed online extraction of the patterns of firing of hippocampal cells during memory tasks to provide effective pulses of microstimulation in real time [128] . Similarly, human studies have shown that neuromodulation via DBS of other potential targets such as the medial temporal lobe can significantly improve tasks of verbal recall [130] and spatial memory [11, 131] . More recently, Ezzyat et al., demonstrated that these memory enhancements via neuromodulation are dependent on current brain encoding state [132], further supporting the importance of bidirectional (afferent and efferent) BMI [133] . These findings indicate that controlled neuromodulation of specific brain targets may be used in the future to treat patients with memory disorders and cognitive dysfunctions. As we expand our understanding of the circuitry involved in the acquisition, consolidation, and retrieval of memories, the efficacy of current cognitive prostheses can improve significantly by using micro-neuromodulation with high spatial and temporal precision. Even though the implementation of these type of neuroprostheses might have unparalleled clinical applications, several ethical questions are important to discuss [134] .
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stimulation has been the gold standard for the vast majority of aforementioned neuroprosthetic successes [60] ( Figure 3A ). Novel silicon microelectrodes [136] [137] [138] have systematically become denser by decreasing the size and increasing the number of electrode sites [32] . Even though performance variability occurs among different site locations [46, 139] , when compared to regular single-site microelectrodes [135] , high-density microelectrodes allow independent placing of electrode sites within a single shaft, improving focal selectivity within cortical layers [140] . Task-specific design of microelectrodes can greatly benefit the selectivity and functionality necessary for particular neuroprosthetic applications. Advances in design and microfabrication, such as electron-beam lithography [141] and active CMOS electronic units [142] would allow for an increased number of traces and independent stimulation channels [143] . This next generation of microelectromechanical systems (MEMS) would greatly propel forward both microstimulation and recording capabilities [143] . In addition to conventional MEMS, the mechanical, electrical, and particularly, dimensional properties of carbon fibers have proven to be an attractive alternative to the manufacture of chronic electrical microelectrodes [144-146]( Figure 3B ). Even though these penetrating electrodes have been mostly developed as recording devices (essential for bidirectional BMI) [133] , discrete modifications can be done to achieve electrostimulation [147, 148] . Additionally, advances in material composition, compatibility, and deposition techniques have allowed a variety of microelectrode designs with different substrate profiles [36]. These advances have led to novel electrode designs that can potentially mediate the scale of the FBR, such as: mechanically dynamic probes [45], ultraflexible nanoelectronic threads [149] , injectable mesh electrodes [150, 151] , as well as, endovascular stent electrodes [152] . Further studies are necessary to assess the chronic performance of these novel interfaces, as well as, their potential ability to neuromodulate surrounding neurons. Despite their obvious functional and theoretical advantages, penetrating microelectrodes face several practical challenges, primarily, biocompatibility-related. Device implantation inherently causes trauma, including blood-brain-barrier disruption [15] , and neuronal death [38] . This initiates a FBR [37] by the immune system that triggers microglia [154, 155] and astrocyte activation [156] leading to the formation of an indwelling glial sheath that surrounds the electrode [38-40] ( Figure 2 ). Even though, this encapsulating glial sheath, as well as neuronal death, has been primarily associated with chronic decline in recordings [157, 158] and not in stimulation [77], there is literature suggesting that the FBR might have a role in, hindering chronic performance of focal micro-neuromodulation [140] ( Figure 3A ).
Several multidisciplinary efforts are currently developing strategies to mitigate these effects [44], including electrical [47, 48, 159] , mechanical [45,49-51], and chemical approaches [52, [55] [56] [57] [58] [59] that may result in more biomimetic interfaces. A less invasive electrical microstimulation alternative is the use of intracranial electrode grid placed over the cortical surface denominated electrocorticography (ECoG) arrays. Microstimulation in humans with these devices have shown success [78] (see Somatosensory Neuroprostheses section). Likewise, novel reduced-size μECoG arrays [160, 161] have shown great potential. However, the spatial resolution and effective neuromodulation of these are limited to the cortex, excluding critical deeper neuromodulation targets.
Overview of foreign body response to intracortical microelectrodes. Pre-implant phase (left) showing undisrupted tissue. Post-implant acute phase (center), characterized by mechanical brain blood barrier disruption and local bleeding (depicted in red), neuronal death, and activation of microglia. Chronic phase (right), characterized by additional neuronal death and astrocytic glial sheath surrounding the electrode, potentially impairing its performance.
Magnetic
A conventional alternative to standard electrical stimulation is the use of induced electric fields from magnetic stimulation to modulate neural activity; such is the case of TMS. Through large hand-held coils that induce strong magnetic fields, TMS is able to modulate brain activity through the scalp [162] . TMS is commonly used for the treatment of neurological disorders, including, depression [15] and stroke [120] . Analogously, implantable-sized microcoils are capable of reaching neuronal activation thresholds through micromagnetic stimulation (µMS) [163] . This novel µMS technology offers several advantages over conventional electrical stimulation, including, potential MRI compatibility [163] and, high spatial resolution (<60 μm) [164] . Additionally, the focused spatial selectivity due to the asymmetric nature of elicited magnetic fields can selectively activate [164, 165] , or suppress [166] neurons depending on the coil orientation ( Figure 3C ). Moreover, neuronal modulation through the FBR may improve chronic performance of µMS relative to micro-electrical stimulation. Compared to conventional microelectrodes, these microcoils require a much higher power input to modulate neuronal activity [164, 166] . Novel microcoil designs and materials can potentially reduce this power, as well as, dramatically increase their selectivity. Furthermore, additional longitudinal in vivo studies will help to validate the potential of µMS as a viable and safe micro-neuromodulation mechanism.
Optical neuromodulation, through cell-type specific genetically-inserted light-sensitive proteins (opsins) [167] , opened the door for a different microstimulation paradigm, known as optogenetic neuromodulation [168] . In the past decade, optogenetics has been established as a powerful tool for neuroscience research [168, 169] . Advances in optogenetic systems [170] , as well as the ability to selectively activate or inhibit specific cell types [167] ( Figure 3D ), has increased interest in optogenetic neuromodulation technologies [171] . Yet, this nascent technology faces many challenges for neuroprosthetic implementation, including low temporal resolution, complex interfaces, and more importantly, the necessity to genetically manipulate cells [167, 168, 172, 173] . In this manner, multidisciplinary efforts to overcome some of these challenges have shown recent success. These include, subverting the need for genetic manipulation through gold nanoparticles [174] , as well as the development wireless [175, 176] , fully implanted systems [176, 177] , and improved flexible multifunctional probes [178] . Similarly, implantable μECoG arrays for optogenetic recording and microstimulation have shown recent success [179] . Faster and more sensitive opsins will continue to increase the temporal resolution of this technique [143] . Analogously, the spatial resolution could be drastically improved by reductions in probe size and highly selective genetic labeling. Furthermore, advances in high-resolution genetic tagging efforts analogous to nucleotide barcoding [180] and Brainbow labeling [181] , might one day allow micro-neuromodulation at cellular and sub-cellular resolution.
Chemical and Thermal
Alternatively, chemical and thermal neuromodulation technologies have also been proposed. Optically-induced thermal neuromodulation technologies, such as infrared neural stimulation (INS) [182] do not require genetic manipulation [139] . In vivo studies have shown that INS is able to effectively modulate neuronal activity of visual cortex [183] and peripheral nerves [182] with high selectivity [184] . Nevertheless, absence of thermally induced damage, spatiotemporal resolution, and chronic stability are yet to be proven in longitudinal studies [139] . On the other hand, selective injection of neurotransmitters [185], charged ions [186], or temperature-sensitive magnetic nanoparticles (MNP) [187, 188] are capable of modulating neuronal activity with high precision [19] . Recently, a method of stimulation called magneto-thermal genetic stimulation was tested for the first time in freely behaving rats. Combining MNPs with non-invasive alternating magnetic fields, this stimulation method allows for high specificity of genetically-modified cells [189] . However, these technologies require further improvements in stimulation onsets. Currently, poor temporal resolution renders these neuromodulation technologies unfeasible for real-time neuroprostheses. 
Non-invasive Neuromodulation
Non-invasive neuromodulation technologies such as TMS [120] and transcranial current stimulation [122] have been available in the clinic for more than a decade. Even though these methods have the advantage of not requiring invasive procedures, these transcutaneous neuromodulation techniques have poor temporal and spatial resolution. Further, the unwieldy equipment necessary in the case of TMS renders these impractical for chronic neuroprostheses. Nevertheless, recent noninvasive neuromodulation alternatives have emerged with improved spatial resolution. For example, transcranial focused ultrasound (tFUS) has demonstrated neuromodulation recently in human studies that has successfully elicited discrete somatosensory [190, 191] and visual [192] percepts. Likewise, temporal interference (TI) electrical stimulation has recently demonstrated that transcranial electric field interference stimulation is capable of neuromodulation at a selective depth [193] . Further studies will look to demonstrate the practicality and spatiotemporal resolution of these technologies for their application in micro-neuromodulation.
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Conclusion
In conclusion, modern developments from the fields of medicine, neuroscience, and neural engineering are bringing the possibility of micro-neuromodulation closer for prosthetic and science applications. Recent studies in both human and animals have demonstrated the power of high-density, high-resolution neural interfaces to provide sensory, motor, and cognitive effects. Simultaneously, technologies from electronics, optics, and magnetics are continually being miniaturized to provide highdensity, robust interfaces that avoid some biotic failures associated with the FBR. As non-invasive stimulation techniques gradually improve, Short-term solutions to the spatial resolution obstacle will most likely be overcome through invasive penetrating electrodes. Like DBS and cochlear implants, the drawback associated with the implantation of these devices will be outweighed by their clinical success. Furthermore, technological advances in computational power, artificial intelligence, and microelectronics must be developed in parallel as stimulation neuroprostheses become more reliable and precise. As the BMI spotlight shifts from academic and biomedical grounds towards commercial endeavors within the next decade, we will see an inevitable shift from assistive technologies and therapeutics towards sensory augmentation, performance enhancement, and faster-than-thinking communications. Emerging companies such as Neuralink and Kernel are leading pioneering efforts towards these goals. As the incentives for innovation and development of neuroprosthetic interfaces increase, strides towards super-high resolution integrative BMI will continue to flourish. Truly, the ability to selectively micro-neuromodulate every single neuron in the brain will one day become a pillar of neuroscientific research, adding a functional layer of complexity to current multidisciplinary brain mapping initiatives. This paper reports a hypothetical limit in which changes of the flexibility of neural probes can effectively improve chronic performance and biocompatibility.
•46. Lee Novel neuromodulation method capable of selectively stimulating subcortical deep brain regions through non-invasive temporally interfering electric fields.
